Total Payments
$4,683
2024 Payments
$744.66
Companies
26
Transactions
192
Medicare Patients
514
Medicare Billing
$95,126
Payment Breakdown by Category
Food & Beverage$4,683 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,683 | 192 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $846.75 | 22 | $0 (2024) |
| PFIZER INC. | $751.33 | 66 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $667.35 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $494.69 | 15 | $0 (2024) |
| Amgen Inc. | $316.64 | 3 | $0 (2019) |
| ABBVIE INC. | $292.60 | 14 | $0 (2024) |
| Lilly USA, LLC | $211.14 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $185.29 | 4 | $0 (2024) |
| Allergan Inc. | $164.22 | 3 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $137.77 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $744.66 | 39 | ABBVIE INC. ($251.16) |
| 2023 | $789.65 | 31 | GlaxoSmithKline, LLC. ($192.45) |
| 2022 | $352.65 | 16 | Novo Nordisk Inc ($199.12) |
| 2021 | $590.66 | 20 | Novo Nordisk Inc ($257.45) |
| 2020 | $138.53 | 4 | GlaxoSmithKline, LLC. ($126.74) |
| 2019 | $475.77 | 20 | PFIZER INC. ($158.72) |
| 2018 | $882.04 | 28 | Novo Nordisk Inc ($297.75) |
| 2017 | $709.01 | 34 | PFIZER INC. ($294.69) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $122.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $65.42 | General |
| Category: Cardiovascular | ||||||
| 06/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardio-renal | ||||||
| 04/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Respiratory | ||||||
| 04/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes Care | ||||||
| 04/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 68 | 184 | $27,440 | $15,004 |
| 2022 | 3 | 134 | 272 | $39,365 | $24,287 |
| 2021 | 2 | 140 | 321 | $48,025 | $27,974 |
| 2020 | 4 | 172 | 352 | $46,515 | $27,860 |
Total Patients
514
Total Services
1,129
Medicare Billing
$95,126
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 184 | $27,440 | $15,004 | 54.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 215 | $31,175 | $19,458 | 62.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $3,150 | $2,627 | 83.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 36 | $5,040 | $2,202 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 99 | 257 | $39,185 | $23,896 | 61.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 64 | $8,840 | $4,078 | 46.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 107 | 271 | $33,875 | $20,223 | 59.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 18 | 18 | $3,960 | $2,989 | 75.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 23 | $4,600 | $2,623 | 57.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 40 | $4,080 | $2,025 | 49.6% |
About Dr. Norman Floro, MD
Dr. Norman Floro, MD is a Internal Medicine healthcare provider based in Elyria, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124042387.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norman Floro, MD has received a total of $4,683 in payments from pharmaceutical and medical device companies, with $744.66 received in 2024. These payments were reported across 192 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,683).
As a Medicare-enrolled provider, Floro has provided services to 514 Medicare beneficiaries, totaling 1,129 services with total Medicare billing of $95,126. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Elyria, OH
- Active Since 07/27/2006
- Last Updated 08/03/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124042387
Products in Payments
- Ozempic (Drug) $656.67
- TRELEGY ELLIPTA (Drug) $355.16
- Aimovig (Biological) $316.64
- LYRICA (Drug) $314.81
- FARXIGA (Drug) $283.33
- VRAYLAR (Drug) $236.85
- CHANTIX (Drug) $208.46
- BEVESPI AEROSPHERE (Drug) $199.37
- JARDIANCE (Drug) $179.60
- BREZTRI (Drug) $163.25
- CAMZYOS (Drug) $157.25
- LINZESS (Drug) $149.15
- Kerendia (Drug) $137.77
- EUCRISA (Drug) $125.94
- AJOVY (Biological) $123.95
- RYBELSUS (Drug) $100.07
- Rybelsus (Drug) $90.01
- NURTEC ODT (Drug) $71.36
- ENTRESTO (Drug) $67.24
- FreeStyle Libre 2 (Device) $59.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elyria
Dr. Mehdi Shishehbor, Do, DO
Internal Medicine — Payments: $344,898
Internal Medicine $344,898
Ademola Abiose, Md, MD
Internal Medicine — Payments: $131,643
Internal Medicine $131,643
Dr. Sana Abumeri, M.d, M.D
Internal Medicine — Payments: $5,150
Internal Medicine $5,150
Vagesh Hampole, Md, MD
Internal Medicine — Payments: $1,521
Internal Medicine $1,521
Dr. Vijay Kakumanu, M.d, M.D
Internal Medicine — Payments: $1,393
Internal Medicine $1,393
Dr. Niraj Mistry, Md, MD
Internal Medicine — Payments: $1,172
Internal Medicine $1,172